Gap CO2 in Septic Patient to Predict Cardiomyopathy Septic
NCT ID: NCT06326762
Last Updated: 2024-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
98 participants
OBSERVATIONAL
2023-01-01
2023-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Subsequently. the investigators examined the clinical and paraclinical profile of patients with septic cardiomyopathy. the investigators identified 19 patients with this condition, while 79 patients did not exhibit cardiac involvement. The percentage was significantly higher in the population with cardiac involvement, accounting for 28.3%. Among the patients with cardiac involvement, 76.5% had a PCO2 gap (DELTAPCO2) ≥ 6 mmHg, a significantly reduced cardiac output with an average of 3.3 L/min, and a predominantly low cardiac index, with 64.3% having an index \< 2.2 L/min/m². The mortality rate was significantly increased at 73.7%.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CO2 Gap Changes Versus Inferior Vena Cava Collapsibility in Relation to Cardiac Index as a Prognostic Value in Septic Shock
NCT06119815
CO2 Gap Changes in Septic Shock in Relation to Cardiac Output
NCT05578534
Venous to Arterial Carbon Dioxide Difference (P₍ᵥ-ₐ₎CO₂): Predictor of Septic Patient Prognosis Depending on the ScvO₂
NCT03292120
Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients
NCT06256198
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
NCT07179276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myocardial Dysfunction
comparaison
description indicate
No Myocardial Dysfunction
comparaison
description indicate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
comparaison
description indicate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sepsis or septic shock
* at least one echocardiogram and were monitored by pulse wave contour analysis
* stay of 72 hours in the intensive care unit
Exclusion Criteria
* Patients with COVID-19.
* Patients who died within 48 hours of hospitalization.
* Cases with incomplete medical records or patients not monitored.
* Patient with pre-existing cardiac conditions.
* post-operative patients from cardiac and thoracic surgeries.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mohammed VI University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Younes Oujidi
doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
younes Oujidi
Berkane, , Morocco
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
younes
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.